Société de Therapeutique Marocaine S.A. (CBSE:SOT)

Morocco flag Morocco · Delayed Price · Currency is MAD
1,717.00
-44.00 (-2.50%)
At close: Apr 28, 2026
42.85%
Market Cap 13.49B
Revenue (ttm) 3.04B
Net Income (ttm) 345.28M
Shares Out 7.66M
EPS (ttm) 47.96
PE Ratio 37.38
Forward PE n/a
Dividend 28.00 (1.59%)
Ex-Dividend Date Jun 20, 2025
Volume 327
Average Volume 1,368
Open 1,706.00
Previous Close 1,761.00
Day's Range 1,706.00 - 1,754.00
52-Week Range 1,186.00 - 1,950.00
Beta -0.04
RSI 54.63
Earnings Date Apr 28, 2026

About CBSE:SOT

Société de Therapeutique Marocaine S.A., a pharmaceutical company, engages in the manufacturing of licensed medicines in Morocco. It offers products in various therapeutic areas, such as allergology, oncology, cardiology, dental, dermatology, endocrinology, gastroenterology, gynecology, ophthalmology, ENT, pediatric, pulmonology, reanimation, rheumatology, central nervous system (CNS), and urology, as well as antibiotics and generics. The company also provides its products in various forms, including tablets, capsules, pouches, syrups, suspensi... [Read more]

Industry Pharmaceutical Preparations
Founded 1976
Employees 1,219
Stock Exchange Casablanca Stock Exchange
Ticker Symbol SOT
Full Company Profile

Financial Performance

In 2024, CBSE:SOT's revenue was 2.82 billion, an increase of 13.27% compared to the previous year's 2.49 billion. Earnings were 315.29 million, an increase of 19.99%.

Financial Statements

News

There is no news available yet.